MiNK Therapeutics (INKT) Director Ryan Barbara Receives 1,622 RSUs

What Happened

• Ryan Barbara, a director of MiNK Therapeutics (INKT), was granted 1,622 restricted stock units (RSUs) on 2026-09-01. The RSUs are reported at $10.95 per share, with a total grant value of $17,761. This was an award received in lieu of cash board/committee retainers rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-01 (reported on Form 4 filed 2026-09-02, accession 0001193125-26-379518)
• Grant: 1,622 RSUs @ $10.95 per share; total reported value $17,761
• Shares owned after transaction: not specified in the summary provided on this filing
• Footnote: RSUs represent a contingent right to one share each and will vest one month from the grant date (per footnote F1)
• Timeliness: Filing was submitted the day after the transaction (no late filing flag indicated)

Context

• These RSUs are a form of compensation and will convert to common stock upon vesting; they are not an immediate cashless exercise or market purchase. Such grants are common for board members and do not by themselves indicate insider buying or selling intent.